ArticleGene therapy2006

EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.

K S Balaggan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.